Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
Vetsuisse Faculty, Department of Clinical Veterinary Medicine, Bern, Switzerland.
Vet Anaesth Analg. 2021 May;48(3):398-406. doi: 10.1016/j.vaa.2020.10.010. Epub 2021 Feb 3.
To determine the intraoperative and early postoperative opioid requirement after ultrasound-guided sciatic and/or femoral nerve block or epidural anaesthesia in dogs undergoing tibial plateau levelling osteotomy (TPLO).
Prospective, masked, pilot, randomized, clinical trial.
A total of 40 client-owned dogs undergoing TPLO.
Each dog was randomly assigned to group SF (combined sciatic and femoral nerve block), group S (sciatic nerve block), group F (femoral nerve block) or group E (epidural anaesthesia). A total of 0.3 mL kg of ropivacaine 0.5% was administered to each nerve or in the epidural space. Intraoperatively, fentanyl (2 μg kg) was administered intravenously when heart rate, mean arterial pressure or respiratory rate increased by >30% compared with baseline values. Postoperatively, a visual analogue scale (VAS) and a modified German version of the French pain scale (4AVet) were used to assess pain every 30 minutes for 150 minutes and again once the morning after surgery. Methadone (0.1 mg kg) was administered intravenously if the VAS was ≥ 4 cm [maximal value 10 cm; median (interquartile range)] or the composite pain score was ≥5 [maximal value 15; median (interquartile range)]. Significance was defined as p ≤ 0.05.
Groups SF and E required less total intraoperative and early postoperative opioid doses compared with groups S and F (p = 0.031). No dogs in group SF had a block failure or required postoperative methadone. A reduced methadone requirement was found in group SF compared with all the other groups up to 150 minutes after recovery (p = 0.041).
Combined sciatic and femoral nerve block and epidural anaesthesia lead to less cumulative consumption of perioperative opioids than single nerve blockade. Sciatic or femoral nerve block alone might be insufficient to control nociception and early postoperative pain in dogs undergoing TPLO.
确定在接受胫骨平台平整术(TPLO)的犬中,超声引导坐骨神经和/或股神经阻滞或硬膜外麻醉后,术中及术后早期阿片类药物的需求。
前瞻性、盲法、试点、随机、临床试验。
共 40 只接受 TPLO 的患犬。
每只犬随机分配至 SF 组(坐骨神经和股神经联合阻滞)、S 组(坐骨神经阻滞)、F 组(股神经阻滞)或 E 组(硬膜外麻醉)。每只神经或硬膜外腔给予 0.3ml/kg 的罗哌卡因 0.5%。术中,当心率、平均动脉压或呼吸率与基线值相比增加超过 30%时,静脉给予芬太尼(2μg/kg)。术后,使用视觉模拟评分(VAS)和改良的法国疼痛评分(4AVet)每 30 分钟评估疼痛 150 分钟,并在术后第二天再次评估。如果 VAS 评分≥4cm[最大值 10cm;中位数(四分位距)]或复合疼痛评分≥5[最大值 15;中位数(四分位距)],则静脉给予美沙酮(0.1mg/kg)。p≤0.05 为差异有统计学意义。
SF 组和 E 组的术中及术后早期阿片类药物总用量均少于 S 组和 F 组(p=0.031)。SF 组无阻滞失败或术后需要美沙酮。SF 组在恢复后 150 分钟内,与其他所有组相比,美沙酮的需求减少(p=0.041)。
坐骨神经和股神经联合阻滞及硬膜外麻醉可减少围手术期阿片类药物的累积用量,而单一神经阻滞则不然。单独的坐骨神经或股神经阻滞可能不足以控制接受 TPLO 的犬的伤害感受和术后早期疼痛。